Azithromycin for Typhoid Fever Treatment

Efficacy of Azithromycin for Typhoid Fever

Azithromycin demonstrates superior outcomes with lower risk of clinical failure (OR 0.48) and shorter hospital stays (-1.04 days) compared to fluoroquinolones for uncomplicated typhoid fever 1
Azithromycin shows significantly lower risk of relapse (OR 0.09) compared to ceftriaxone 1

For fully sensitive Salmonella typhi: fluoroquinolones remain first-line, with azithromycin as an alternative 1
For multidrug-resistant strains: fluoroquinolone or cefixime, with azithromycin as an alternative 1
For quinolone-resistant strains: azithromycin or ceftriaxone is recommended as first-line therapy 1
In areas with high fluoroquinolone resistance (>70% of S. typhi and S. paratyphi isolates in the UK), azithromycin is a suitable oral alternative for uncomplicated disease 3

Blood cultures should be obtained before starting antibiotics when possible, as they have the highest yield within the first week of symptom onset 3
Azithromycin sensitivity testing is not readily available in many settings, though resistance remains relatively rare in the UK and many other regions 3
Complications of typhoid fever (gastrointestinal bleeding, intestinal perforation, typhoid encephalopathy) occur in 10-15% of patients and are more likely if duration of illness exceeds 2 weeks 3
Vaccination provides incomplete protection against typhoid fever and does not protect against paratyphoid 3

For suspected or confirmed typhoid fever in areas with known fluoroquinolone resistance: azithromycin 20 mg/kg/day (max 1g/day) for 7-14 days 1
For severe cases requiring parenteral therapy: ceftriaxone initially, with transition to oral azithromycin when tolerated 3
For uncomplicated cases in areas with low fluoroquinolone resistance: fluoroquinolones remain first-line, with azithromycin as an alternative 1